{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Drozitumab",
  "nciThesaurus": {
    "casRegistry": "912628-39-8",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "",
    "fdaUniiCode": "SQ67484MA7",
    "identifier": "C95784",
    "preferredName": "Drozitumab",
    "semanticType": "Amino Acid, Peptide, or Protein",
    "subclassOf": [
      "C20401"
    ],
    "synonyms": [
      "Anti-DR5 Monoclonal Antibody",
      "DROZITUMAB",
      "Drozitumab",
      "Immunoglobulin G1, anti-(human tumor necrosis factor receptor superfamily member 10B (death receptor 5, TRAIL-R2, CD262 antigen)); [113-lysine,116-threonine,360-glutamic acid,362-methionine]human monoclonal gamma-1 heavy chain (224-212')-disulfide with human monoclonal lambda-3 light chain (230-230'':233-233'')-bisdisulfide dimer",
      "PRO95780",
      "rhuMAb DR5"
    ]
  }
}